Age at onset in axial spondyloarthritis around the world: data from the Assessment in SpondyloArthritis international Society Peripheral Involvement in Spondyloarthritis study

dc.contributor.authorBoel, Anne
dc.contributor.authorLopez-Medina, Clementina
dc.contributor.authorvan der Heijde, Desiree M. F. M.
dc.contributor.authorvan Gaalen, Floris Alexander
dc.contributor.authoraffiliation[Boel, Anne] Leiden Univ Med Ctr, Rheumatol Dept, Leiden, Netherlands
dc.contributor.authoraffiliation[van der Heijde, Desiree M. F. M.] Leiden Univ Med Ctr, Rheumatol Dept, Leiden, Netherlands
dc.contributor.authoraffiliation[van Gaalen, Floris Alexander] Leiden Univ Med Ctr, Rheumatol Dept, Leiden, Netherlands
dc.contributor.authoraffiliation[Lopez-Medina, Clementina] Cochin Hosp, AP HP, Rheumatol Dept, Paris, France
dc.contributor.authoraffiliation[Lopez-Medina, Clementina] Univ Paris, INSERM Clin Epidemiol & Biostat U1153, Paris, France
dc.contributor.authoraffiliation[Lopez-Medina, Clementina] Reina Sofia Univ Hosp, Maimonides Inst Biomed Res Cordoba, Rheumatol Dept, Cordoba, Spain
dc.contributor.funderAbbVie
dc.contributor.funderPfizer
dc.contributor.funderEli Lilly
dc.contributor.funderNovartis
dc.contributor.funderUCB
dc.contributor.funderJanssen
dc.contributor.funderMerck
dc.date.accessioned2025-01-07T13:27:26Z
dc.date.available2025-01-07T13:27:26Z
dc.date.issued2021-09-22
dc.description.abstractObjective Age at onset is useful in identifying chronic back patients at an increased risk of axial SpA (axSpA). However, the majority of data on which the criterion of age at onset Methods Analyses were applied to patients from 24 countries across the world with an axSpA diagnosis and known age at onset of axial complaints. Cumulative probability plots were used to display the cumulative distribution of age at onset of axial symptoms. Linear regression models were built to assess the effect of HLA-B27 and gender on age at onset of axial symptoms. Results Of 2579 axSpA patients, 92% had an age at onset of axial symptoms
dc.identifier.doi10.1093/rheumatology/keab544
dc.identifier.essn1462-0332
dc.identifier.issn1462-0324
dc.identifier.pmid34260699
dc.identifier.unpaywallURLhttps://academic.oup.com/rheumatology/article-pdf/61/4/1468/43355925/keab544.pdf
dc.identifier.urihttps://hdl.handle.net/10668/25529
dc.identifier.wosID756527600001
dc.issue.number4
dc.journal.titleRheumatology
dc.journal.titleabbreviationRheumatology
dc.language.isoen
dc.organizationSAS - Hospital Universitario Reina Sofía
dc.organizationInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)
dc.page.number1468-1475
dc.publisherOxford univ press
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.subjectaxial spondyloarthritis
dc.subjectage at onset
dc.subjectHLA-B27
dc.subjectgender
dc.subjectInflammatory back-pain
dc.subjectAnkylosing-spondylitis
dc.subjectClassification criteria
dc.subjectPositive patients
dc.subjectDisease onset
dc.subjectDiagnosis
dc.titleAge at onset in axial spondyloarthritis around the world: data from the Assessment in SpondyloArthritis international Society Peripheral Involvement in Spondyloarthritis study
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number61
dc.wostypeArticle

Files